Publications by authors named "Ulrich Hacker"

Claim this Profile
A
Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies.
Angela E Araujo, Martin Bentler, Xabier Perez Garmendia, Asma Kaleem, Claire Fabian, Ulrich T Hacker

Hum Gene Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional Response of -Mutated Acinar Cell CUP to BRAF/MEK Inhibition.
Irina A Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, Gertraud Stocker, G G Ruth Hiller, Ulrich T Hacker

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunotherapy for gastrointestinal cancer].
Getraud Stocker, Ulrich Hacker, Florian Lordick

Dtsch Med Wochenschr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative bioinformatic analysis of KRAS, STK11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C.
Myriam Boeschen, Christina Katharina Kuhn, Hubert Wirtz, Hans-Jürgen Seyfarth, Armin Frille, Ulrich T Hacker

Lung Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Maria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm, Michael Stahl, Boris Kubuschok, Ulrich T Hacker

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study).
Andrea Alberti, Gertraud Stocker, Florian Lordick, Ulrich T Hacker, Benjamin Kobitzsch

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifying immune responses to adeno-associated virus vectors by capsid engineering.
Martin Bentler, Romain Hardet, Moritz Ertelt, Daniela Rudolf, Dorota Kaniowska, Ulrich T Hacker

Mol Ther Methods Clin Dev· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy.
Ann-Christin Franke, Romain Hardet, Lisa Prager, Martin Bentler, Mélanie Demeules, Ulrich Thorsten Hacker

Mol Ther Methods Clin Dev· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the way to developing AAV-based vaccines as novel tools for cancer immunotherapy.
Ulrich T Hacker

Mol Ther Methods Clin Dev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[What is confirmed in the treatment of colon cancer?].
Florian Lordick, Ulrich Hacker, Albrecht Hoffmeister, Hendrik Bläker, Ines Gockel

Inn Med (Heidelb)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7].
C Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I Gaidzik, Ulrich T Hacker

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors.
Nadja Meumann, Christian Schmithals, Leroy Elenschneider, Tanja Hansen, Asha Balakrishnan, Ulrich T Hacker

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients.
Silvia Catanese, Carl Friedrich Beuchel, Teresa Sawall, Florian Lordick, Rommy Brauer, Ulrich T Hacker

J Cachexia Sarcopenia Muscle· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gastric Cancer: diagnosis and current treatment strategies].
Ulrich Hacker, Albrecht Hoffmeister, Florian Lordick

Dtsch Med Wochenschr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View.
Justus Körfer, Florian Lordick, Ulrich T Hacker

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses.
Allan Scarpitta, Ulrich T Hacker, Hildegard Büning, Olivier Boyer, Sahil Adriouch

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'.
Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I Gaidzik, Ulrich T Hacker

Eur J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.
Ulrich T Hacker, Martin Bentler, Dorota Kaniowska, Michael Morgan, Hildegard Büning

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial.
Ulrich T Hacker, Dirk Hasenclever, Nicolas Linder, Gertraud Stocker, Hyun-Cheol Chung

J Cachexia Sarcopenia Muscle· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact.
Radka Obermannova, Dalibor Valik, Dirk Hasenclever, Lenka Zdrazilova-Dubska, Ulrich Hacker

Eur J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy: New Options in Gastrointestinal Cancers?
Andrea Tannapfel, Anke Reinacher-Schick, Ulrich Hacker, Sylvie Lorenzen, Markus Möhler

Visc Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer.
Rüdiger Klapdor, Shuo Wang, Michael Morgan, Thilo Dörk, Ulrich Hacker

Int J Mol Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
Gertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, Jestinah John Mahachie, Arnaud D Roth

Eur J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.
Maren Knödler, Justus Körfer, Volker Kunzmann, Jörg Trojan, Severin Daum, Ulrich Hacker

Br J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy.
Rüdiger Klapdor, Shuo Wang, Ulrich Hacker, Hildegard Büning, Michael Morgan

Hum Gene Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis